chitosan has been researched along with acyclovir in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 10 (28.57) | 29.6817 |
| 2010's | 15 (42.86) | 24.3611 |
| 2020's | 8 (22.86) | 2.80 |
| Authors | Studies |
|---|---|
| Conti, B; Genta, I; Pavanetto, F; Perugini, P; Puglisi, G; Spadaro, A | 1 |
| Conti, B; Genta, I; Modena, T; Muzzarelli, RA; Pavanetto, F; Perugini, P | 1 |
| Bonferoni, MC; Caramella, C; Ferrari, F; Rossi, S; Sandri, G | 1 |
| Bonferoni, MC; Caramella, C; Ferrari, F; Muzzarelli, C; Rossi, S; Sandri, G | 1 |
| Hippalgaonkar, K; Majumdar, S; Repka, MA | 1 |
| Bonferoni, MC; Caramella, C; Ferrari, F; Gibin, S; Rossi, S; Sandri, G | 1 |
| Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P | 1 |
| Dhaliwal, S; Jain, S; Singh, HP; Tiwary, AK | 1 |
| Laranjeira, MC; Murakami, FS; Silva, MA; Stulzer, HK; Tagliari, MP | 1 |
| Al-Robayan, AA; Alanazi, FK; Alsarra, IA; El Maghraby, GM; Hamed, AY; Mahrous, GM | 1 |
| Christoffersen, C; El-Kattan, A; Merzlikine, A; Poe, J; Rago, B; Rotter, C; Thomas, VH; Troutman, M | 1 |
| Hasanovic, A; Reznicek, G; Valenta, C; Zehl, M | 1 |
| Fischinger, K; Hasanovic, A; Hollick, C; Valenta, C | 1 |
| Refai, H; Tag, R | 1 |
| Hasanovic, A; Resch, GP; Valenta, C; Winkler, R | 1 |
| Aiba, T; Goto, Y; Kurosaki, Y; Masuda, A | 1 |
| Gago-Guillan, M; Otero-Espinar, FJ; Ruiz-Caro, R; Veiga, MD | 1 |
| Adriaens, E; Calderón, L; Cordoba-Diaz, D; Cordoba-Diaz, M; Elorza, B; Elorza, M; Harris, R; Heras, A; Lenoir, J; Remon, JP | 1 |
| Al-Kassas, R; Chalabi, S; In Kim, JH; Langford, C; Painter, S; Seyfoddin, A; Svirskis, D | 1 |
| Kubbinga, M; Langguth, P; Nguyen, MA; Staubach, P; Teerenstra, S | 1 |
| Ahmed, TA; Al-Subaie, MM; Aljaeid, BM; El-Say, KM; Hosny, KM | 1 |
| Abad, MJ; Bedoya, LM; Bermejo, P; Carro, R; Fernández-Ferreiro, A; Martín-Illana, A; Otero-Espinar, F; Rubio, J; Ruiz-Caro, R; Sánchez-Sánchez, MP; Tamayo, A; Veiga, MD | 1 |
| Srinivas, NR | 1 |
| Al-Kassas, R; McGhee, CN; Patel, DV; Rupenthal, ID; Seyfoddin, A; Sherwin, T; Taylor, JA | 1 |
| Ates, M; Kaynak, MS; Sahin, S | 1 |
| Augustijns, P; García, MA; Heinen, C; Kubbinga, M; Langguth, P; Verwei, M; Wortelboer, HM | 1 |
| Adnan, S; Hanif, M; Ranjha, NM | 1 |
| Amirian, J; Du, B; Shekh, MI; Stadler, FJ; Zhu, Y | 1 |
| Argenziano, M; Bastiancich, C; Cavalli, R; Civra, A; Donalisio, M; Lembo, D; Rittà, M | 1 |
| Bou-Chacra, NA; Consiglieri, VO; Gonçalves, JE; Löbenberg, R; Monteiro, LM; Storpirtis, S; Tavares, GD | 1 |
| Chien, TC; Hilles, AR; Kiong, KC; Mahmood, S; Tham, CS; Venugopal, JR | 1 |
| Deshkar, S; Kale, R; Sikchi, S; Thakre, A | 1 |
| Ahmad, M; Alqahtani, MS; Barkat, K; Khan, MT; Mahmood, A; Malik, NS; Rashid, A; Tulain, UR | 1 |
| Abd-Elsalam, WH; Ibrahim, RR | 1 |
| Al-Gousous, J; García, MA; Hensler, G; Langguth, P; Lennernäs, H; Pielenhofer, J; Wagner, M | 1 |
1 review(s) available for chitosan and acyclovir
| Article | Year |
|---|---|
Microparticulate drug delivery systems.
Topics: Acyclovir; Animals; Antiviral Agents; Biocompatible Materials; Capsules; Chitin; Chitosan; Drug Carriers | 1999 |
1 trial(s) available for chitosan and acyclovir
| Article | Year |
|---|---|
The Influence of Chitosan on the Oral Bioavailability of Acyclovir--a Comparative Bioavailability Study in Humans.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Biological Availability; Chitosan; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Drug Carriers; Female; Healthy Volunteers; Humans; Male | 2015 |
33 other study(ies) available for chitosan and acyclovir
| Article | Year |
|---|---|
Bioadhesive microspheres for ophthalmic administration of acyclovir.
Topics: Acyclovir; Adhesives; Animals; Antiviral Agents; Aqueous Humor; Biological Availability; Chemistry, Pharmaceutical; Chitin; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Female; Microspheres; Ophthalmic Solutions; Photomicrography; Rabbits; X-Ray Diffraction | 1997 |
Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid.
Topics: Absorption; Acrylic Resins; Acyclovir; Adhesiveness; Administration, Oral; Animals; Antimetabolites; Cheek; Chitin; Chitosan; Drug Delivery Systems; Excipients; In Vitro Techniques; Mouth Mucosa; Nephelometry and Turbidimetry; Swine; Viscosity | 2003 |
Assessment of chitosan derivatives as buccal and vaginal penetration enhancers.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Administration, Buccal; Administration, Intravaginal; Animals; Area Under Curve; Chitosan; Female; Models, Biological; Molecular Weight; Mouth Mucosa; Permeability; Pharmaceutical Solutions; Polymers; Pyrrolidinones; Swine; Time Factors; Vagina | 2004 |
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Animals; Antiviral Agents; Benzalkonium Compounds; Chitosan; Cornea; Drug Synergism; Edetic Acid; In Vitro Techniques; Male; Permeability; Rabbits | 2008 |
Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Administration, Intravaginal; Animals; Biological Availability; Caco-2 Cells; Carboxypeptidases A; Cell Survival; Chitosan; Ciprofloxacin; Dextrans; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Leucyl Aminopeptidase; Mucous Membrane; Protease Inhibitors; Sus scrofa; Vaginal Creams, Foams, and Jellies; Viscosity | 2008 |
In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Topics: Acyclovir; Animals; Antiviral Agents; beta-Cyclodextrins; Biological Transport; Caco-2 Cells; Cell Line; Cell Survival; Chitosan; Dogs; Drug Synergism; Electric Impedance; Excipients; Humans; Kidney; Mannitol; Permeability; Sodium Dodecyl Sulfate | 2008 |
Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
Topics: Acrylates; Acyclovir; Administration, Oral; Animals; Antiviral Agents; Chitosan; Drug Carriers; Gastric Mucosa; In Vitro Techniques; Intestinal Mucosa; Methylcellulose; Microspheres; Particle Size; Rats; Rats, Sprague-Dawley; Solubility; Surface Properties; Swine; Tissue Adhesives; Tissue Distribution | 2008 |
Development and validation of an RP-HPLC method to quantitate acyclovir in cross-linked chitosan microspheres produced by spray drying.
Topics: Acyclovir; Antiviral Agents; Chitosan; Chromatography, High Pressure Liquid; Microspheres; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir.
Topics: Acrylates; Acyclovir; Adhesiveness; Administration, Intranasal; Animals; Chitosan; Cross-Linking Reagents; Drug Carriers; Excipients; Glycerol; Hydrogels; Nasal Mucosa; Polyethylene Glycols; Povidone; Sheep; Technology, Pharmaceutical | 2009 |
Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Topics: Acrylates; Acyclovir; Animals; Antiviral Agents; Area Under Curve; Caco-2 Cells; Cell Membrane Permeability; Chemistry, Pharmaceutical; Chitosan; Chromatography, High Pressure Liquid; Edetic Acid; Electric Impedance; Excipients; Glutamates; Humans; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley | 2009 |
Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability.
Topics: Acyclovir; Antiviral Agents; Calorimetry; Chitosan; Drug Carriers; Drug Stability; Gels; Humans; Lipid Bilayers; Nanoparticles; Particle Size; Permeability; Polyphosphates; Skin; Skin Absorption; Temperature | 2009 |
Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acyclovir; Animals; Calorimetry, Differential Scanning; Cations; Chitosan; Hydrogen Bonding; In Vitro Techniques; Liposomes; Minoxidil; Particle Size; Phase Transition; Polymers; Polymethacrylic Acids; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Swine | 2010 |
Development and characterization of sponge-like acyclovir ocular minitablets.
Topics: Acyclovir; Animals; Antiviral Agents; Chemistry, Pharmaceutical; Chitosan; Columbidae; Delayed-Action Preparations; Eye; Freeze Drying; Gels; Keratitis, Herpetic; Particle Size; Polymers; Rabbits; Simplexvirus; Tablets; Viscosity; Vision, Ocular | 2011 |
Modification of the conformational skin structure by treatment with liposomal formulations and its correlation to the penetration depth of aciclovir.
Topics: Abdomen; Acyclovir; Animals; Antiviral Agents; Biocompatible Materials; Chitosan; Drug Compounding; Drug Delivery Systems; Drug Evaluation, Preclinical; Ear; Epidermis; Humans; Lipids; Liposomes; Permeability; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Swine; Water Loss, Insensible | 2011 |
In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
Topics: Acyclovir; Animals; Antiviral Agents; Chitosan; Glycoside Hydrolases; Intestinal Absorption; Jejunum; Male; Pharmaceutical Vehicles; Rats; Rats, Wistar; Streptomyces; Viscosity | 2012 |
Mucoadhesive tablets for controlled release of acyclovir.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Chitosan; Delayed-Action Preparations; Gastric Mucosa; Humans; Hypromellose Derivatives; Methylcellulose; Swine; Tablets; Tissue Adhesives | 2012 |
Nano and microparticulate chitosan-based systems for antiviral topical delivery.
Topics: Acyclovir; Administration, Topical; Alkaline Phosphatase; Animals; Antiviral Agents; Chitosan; Drug Delivery Systems; Gastropoda; L-Lactate Dehydrogenase; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Toxicity Tests, Acute; X-Ray Diffraction | 2013 |
Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties.
Topics: Acyclovir; Adhesiveness; Administration, Oral; Animals; Antiviral Agents; Chemistry, Pharmaceutical; Chickens; Chitosan; Delayed-Action Preparations; Humans | 2014 |
Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections.
Topics: Acyclovir; Animals; Biological Availability; Chitosan; Eugenol; Herpes Simplex; Hydrogels; Male; Models, Theoretical; Molecular Weight; Nanoparticles; Nanotechnology; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption | 2015 |
Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.
Topics: Acyclovir; Carrageenan; Cell Line; Cell Survival; Chitosan; Herpes Genitalis; Humans | 2015 |
The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?
Topics: Acyclovir; Adhesiveness; Administration, Oral; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Excipients; Humans; Intestinal Absorption; Permeability; Terfenadine | 2016 |
Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir.
Topics: Acyclovir; Administration, Ophthalmic; Biological Availability; Chitosan; Cornea; Drug Carriers; Nanostructures | 2016 |
Effect of permeability enhancers on paracellular permeability of acyclovir.
Topics: Acyclovir; Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Chitosan; Colon; Decanoic Acids; Drug Compounding; Excipients; Female; Ileum; Intestinal Absorption; Jejunum; Perfusion; Permeability; Rats, Sprague-Dawley; Sodium Dodecyl Sulfate | 2016 |
The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir.
Topics: Acyclovir; Animals; Antiviral Agents; Biocompatible Materials; Caco-2 Cells; Chitosan; Drug Interactions; Humans; Intestinal Absorption; Jejunum; Organ Culture Techniques; Permeability; Rats; Swine | 2019 |
Synthesis of N,O-Carboxymethyated chitosan and its application in the development of acyclovir loaded nanoparticles.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Liberation; Microscopy, Electron, Scanning; Nanoparticles; Solubility; Spectroscopy, Fourier Transform Infrared | 2019 |
Oxidized chitosan modified electrospun scaffolds for controllable release of acyclovir.
Topics: Acyclovir; Antiviral Agents; Cell Proliferation; Chitosan; Drug Carriers; Drug Liberation; Humans; Kinetics; Magnetic Resonance Spectroscopy; Nanofibers; Oxidation-Reduction; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Tissue Scaffolds; X-Ray Diffraction | 2020 |
Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections.
Topics: Acyclovir; Antiviral Agents; beta-Cyclodextrins; Chitosan; Ethers; Female; Herpesvirus 2, Human; Humans | 2020 |
N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir.
Topics: Acyclovir; Caco-2 Cells; Chitosan; Drug Carriers; Enbucrilate; Humans; Nanoparticles; Particle Size | 2020 |
PEGylated Lipid Polymeric Nanoparticle-Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation.
Topics: Acyclovir; Animals; Antiviral Agents; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Stability; Intestinal Absorption; Lecithins; Lipids; Nanoparticles; Particle Size; Polyethylene Glycols; Rabbits | 2020 |
Poloxamer Modified Chitosan Nanoparticles for Vaginal Delivery of Acyclovir.
Topics: Acyclovir; Animals; Chitosan; Delivery, Obstetric; Drug Carriers; Female; HeLa Cells; Humans; Nanoparticles; Poloxamer; Pregnancy; Rats; Rats, Wistar | 2021 |
β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.
Topics: Acrylamides; Acyclovir; Animals; Antiviral Agents; Area Under Curve; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Liberation; Female; Hydrogels; Hydrogen-Ion Concentration; Metabolic Clearance Rate; Methacrylates; Rabbits; Rats; Rats, Wistar; Surface Properties | 2021 |
Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Delivery Systems; Hexoses; Lipids; Nanoparticles; Particle Size; Vitamin E | 2021 |
Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucus.
Topics: Acyclovir; Chitosan; Excipients; Food-Drug Interactions; Humans; Intestinal Absorption; Mucus | 2023 |